1. The PSRC1 rs599839 A>G variant disentangles the risk of coronary artery disease and hepatocellular carcinoma in Italian NAFLD patients. (February 2020) Authors: Meroni, M.; Longo, M.; Rametta, R.; Alisi, A.; Miele, L.; Valenti, L.; Fracanzani, A.L.; Dongiovanni, P. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. TM6SF2/PNPLA3/MBOAT7 loss-of-function genetic variants impact on NAFLD development and progression both in patients and in in vitro models. (February 2020) Authors: Longo, M.; Meroni, M.; Erconi, V.; Alisi, A.; Miele, L.; Rametta, R.; Fracanzani, A.L.; L.Valenti, ; Dongiovanni, P. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Validation of Interleukin-32 as a new circulating fatty liver biomarker. (February 2020) Authors: Baselli, G.A.; Dongiovanni, P.; Rametta, R.; Meroni, M.; Pelusi, S.; Maggioni, M.; Badiali, S.; Pingitore, P.; Maurotti, S.; Montalcini, T.; Taliento, A.E.; Prati, D.; Rossi, G.; Fracanzani, A.L.; Mancina, R.M.; Romeo, S.; Valenti, L.V.C. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗